» Articles » PMID: 36644227

Specific Polysubstance Use Patterns Predict Relapse Among Patients Entering Opioid Use Disorder Treatment

Overview
Specialty Psychiatry
Date 2023 Jan 16
PMID 36644227
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: While polysubstance use has consistently been associated with higher rates of relapse, few studies have examined subgroups with specific combinations and time course of polysubstance use (i.e., polysubstance use patterns). This study aimed to classify and compare polysubstance use patterns, and their associations with relapse to regular opioid use in 2637 participants in three large opioid use disorder (OUD) treatment trials.

Methods: We explored the daily patterns of self-reported substance use in the 28 days prior to treatment entry. Market basket analysis (MBA) and repeated measure latent class analysis (RMLCA) were used to examine the subgroups of polysubstance use patterns, and multiple logistic regression was used to examine associations between identified classes and relapse.

Results: MBA and RMLCA identified 34 "associations rules " and 6 classes, respectively. Specific combinations of polysubstance use and time course (high baseline use and rapid decrease of use prior to initiation) predicts a worse relapse outcome. MBA showed individuals who co-used cocaine, heroin, prescription opioids, and cannabis had a higher risk for relapse (OR = 2.82, 95%CI = 1.13, 7.03). In RMLCA, higher risk of relapse was observed in individuals who presented with high baseline prescription opioid (OR = 1.9, 95% CI = 1.3, 2.76) or heroin use (OR = 3.54, 95%CI = 1.86, 6.72), although use decreased in both cases prior to treatment initiation.

Conclusions: Our analyses identified subgroups with distinct patterns of polysubstance use. Different patterns of polysubstance use differentially predict relapse outcomes. Interventions tailored to these individuals with specific polysubstance use patterns prior to treatment initiation may increase the effectiveness of relapse prevention.

Citing Articles

Animal models of cocaine use: importance of social context and co-use.

Allen M, Nader M Trends Pharmacol Sci. 2025; 46(3):220-230.

PMID: 39875301 PMC: 11890930. DOI: 10.1016/j.tips.2025.01.003.


Factors Associated with Relapses in Alcohol and Substance Use Disorder.

Yazici A, Bardakci M Eurasian J Med. 2024; 55(1):S75-S81.

PMID: 39128053 PMC: 11075040. DOI: 10.5152/eurasianjmed.2023.23335.


Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse.

Fogelman N, Tate M, Wemm S, Sullivan L, Hart R, Vacey E Addict Biol. 2024; 29(4).

PMID: 38619491 PMC: 11017971. DOI: 10.1111/adb.13390.


Are you thinking what I'm thinking? Defining what we mean by "polysubstance use.".

Bunting A, Shearer R, Linden-Carmichael A, Williams A, Comer S, Cerda M Am J Drug Alcohol Abuse. 2023; 50(1):1-7.

PMID: 37734160 PMC: 10939915. DOI: 10.1080/00952990.2023.2248360.


Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values.

Odom G, Brandt L, Castro C, Luo S, Feaster D, Balise R PLoS One. 2023; 18(9):e0291248.

PMID: 37682922 PMC: 10490938. DOI: 10.1371/journal.pone.0291248.


References
1.
Vrieze S . Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods. 2012; 17(2):228-43. PMC: 3366160. DOI: 10.1037/a0027127. View

2.
Connor J, Gullo M, Chan G, Young R, Hall W, Feeney G . Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs. Front Psychiatry. 2013; 4:79. PMC: 3736050. DOI: 10.3389/fpsyt.2013.00079. View

3.
Soyka M, Strehle J, Rehm J, Buhringer G, Wittchen H . Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample. Eur Addict Res. 2017; 23(2):97-105. DOI: 10.1159/000468518. View

4.
Ataiants J, Roth A, Mazzella S, Lankenau S . Circumstances of overdose among street-involved, opioid-injecting women: Drug, set, and setting. Int J Drug Policy. 2020; 78:102691. PMC: 7302961. DOI: 10.1016/j.drugpo.2020.102691. View

5.
Lee J, Friedmann P, Kinlock T, Nunes E, Boney T, Hoskinson Jr R . Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. N Engl J Med. 2016; 374(13):1232-42. PMC: 5454800. DOI: 10.1056/NEJMoa1505409. View